Bariatric surgery: An IDF statement for obese Type2 diabetes

J. B. Dixon, P. Zimmet, K. G. Alberti, F. Rubino

Research output: Contribution to journalArticlepeer-review

352 Citations (Scopus)


The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type2 diabetes. It is an effective, safe and cost-effective therapy for obese Type2 diabetes. Surgery can be considered an appropriate treatment for people with Type2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co-morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type2 diabetes and a BMI of 35kg/m2 or more.

Original languageEnglish
Pages (from-to)628-642
Number of pages15
JournalDiabetic Medicine
Issue number6
Publication statusPublished or Issued - Jun 2011

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this